Cellenkos Archives - eDisasterX

Tag: Cellenkos

FDA Grants Orphan Drug Designation to Cellenkos’ CK0803 Tregs for Treatment of Amyotrophic Lateral Sclerosis

October 20, 2025

[ad_1] Orphan Drug Designation granted to CK0803 for Amyotrophic Lateral Sclerosis CK0803 is CNS Homing Tregs expressing CXCR3hi, CXCR7+, LFA1+ CK0803 is planned for Randomized Placebo Control Trial in 2026 HOUSTON, Oct. 20, 2025 /PRNewswire/ — Cellenkos® Inc., […]

Continue Reading →

Tag: Cellenkos

FDA Grants Orphan Drug Designation to Cellenkos’ CK0803 Tregs for Treatment of Amyotrophic Lateral Sclerosis

#Rosal Top Picks

Sunwoda Joins 2026 Sungrow Global Partners Conference to Deepen Global Collaboration and Sustainability

Max Stock Limited Announces Immediate report on Termination of Shareholders’ Agreement and Management Services Agreement

ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Mill Creek Announces Groundbreaking of Amavi Northwest Austin

7-Eleven, Inc. Makes Mornings Flavorful with New Breakfast Favorites and Limited-Time Deals

Natural Grocers® Launches Free Three-Part Class Series to Help Customers Hack Their Health

Mantle Vault Hits $100M Milestone, Cementing Bybit as Premier Gateway for On-Chain Yield

Recent Posts

Sunwoda Joins 2026 Sungrow Global Partners Conference to Deepen Global Collaboration and Sustainability

Max Stock Limited Announces Immediate report on Termination of Shareholders’ Agreement and Management Services Agreement

ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Mill Creek Announces Groundbreaking of Amavi Northwest Austin

7-Eleven, Inc. Makes Mornings Flavorful with New Breakfast Favorites and Limited-Time Deals

eDisasterX